Looking for an easy way to stay up to date on all things #IntestinalCell News? 🧐 Check out the Science News website by @STEMCELLTech and subscribe to our regular newsletters covering the latest research, reviews, industry news, and more. 👇
bit.ly/4kkWMEu
📢 This review in Pharmacological Research comprehensively summarizes the current molecular mechanisms by which #EndoplasmicReticulum stress and #Mitochondrial dysfunction aid #IBD pathogenesis.
Review 🔗 | bit.ly/3Ugq7YP
📢 New research supports CLDN1 as a candidate colorectal cancer-associated marker linked to malignant epithelial-cell states, tumor-associated spatial heterogeneity, invasive phenotype, and Nutlin-3a (−) response.
#OpenAccess👉 : bit.ly/3WpqmkO#ColorectalCancer#IntestinalResearch
Metabolic plasticity enables #ColorectalCancer (CRC) cells to adapt to energy stress, contributing to #tumor progression and therapeutic resistance.
💡Results from a study in Biochemical Pharmacology provide mechanistic insight into the #anticancer activity of aripiprazole and support targeting metabolic plasticity as a therapeutic strategy for #CRC!
Find out more: bit.ly/486Wr3v
Findings from a new study in @cgtnature suggest that targeting the m6A modification pathway holds promise for gastric cancer therapy, as the newly identified METTL3-E2F2-MCU axis plays a key role in regulating mitochondrial calcium homeostasis!
🔗 go.nature.com/47EWDqu#GastricCancer#IntestinalResearch#Mitochondria
Researchers from @UChicago built a comprehensive atlas of cell-type-resolved #chromatin accessibility which provides a comprehensive resource to study gene-regulatory effects in #CrohnsDisease and health.
This atlas in @NatureGenet highlights the cellular complexity underlying Crohn’s disease risk.
🔗 go.nature.com/4dhy8mu
Findings from a study in @jlipidres suggest that loss of ceramide synthases 5/6 exacerbate myristate-induced intestinal endoplasmic reticulum stress in colon epithelial cells.
Find out how accumulation of dhsphingosine may provide protection in the #OpenAccess paper here: bit.ly/4hEXa0a#Colon#EpithelialCells#EndoplasmicReticulum
Study findings reveal an intestinal effector-triggered immunity guard system that couples pore-forming toxin-damage sensing to comprehensive epithelial recovery, with physiological relevance for mucosal homeostasis across metazoans!
Read the #OpenAccess paper here: bit.ly/4xWHuM7#IntestinalResearch#Immunity
Scientists summarized the key intercellular dialogs that regulate fibroblast-to-myofibroblast transition during the onset and progression of intestinal disorders, further analyzing their regulatory mechanisms.
🔍Read the review: bit.ly/47jaouN#IntestinalResearch#FMT
Researchers synthesized recent evidence to propose an updated framework for early gastric carcinogenesis based on field evolution, lineage instability, ecosystem support, and pathway divergence.
Check out this review 👀: bit.ly/3TKyOdy
Findings point to the potential of dietary compounds 🥗 to modulate #IntestinalStemCells as a strategy to alleviate colorectal lesions.
Learn more: bit.ly/4Ap91rT
🔬 Scientists identified functional zebrafish intestinal #StemCells in the proliferative zone of intestinal furrows that can differentiate into nearly all characterized epithelial cell lineages.
Read the #OpenAccess article in @CellReports here: bit.ly/4haXxQ2.
Scientists from The Chinese University of Hong Kong show that the bacteria Agathobacter rectalis has anti #CRC effects in vitro and in vivo! 🦠
Read more in their #OpenAccess article: bit.ly/4xkCtMP.
Extracellular vesicles (EVs) from multiple sources regulate intestinal homeostasis and #inflammation. In this review, read how EVs show promise as biomarkers and targeted therapeutics for precision #IBD care!
🔗 bit.ly/3VjRNfg
🤩 The first patient has been dosed in the phase 1 trial evaluating BHB810, a novel drug for the treatment of #GastricCancer!
🖥️ BHB810 was engineered using @BigHatBio's AI-powered antibody design platform, read more: bit.ly/4zSTjoz
🩺The @FDA has approved @BeOneMedicines's TEVIMBRA®-based regimen for the first-line treatment of adult patients with HER2-positive (HER2+) gastric, gastroesophageal junction, or esophageal adenocarcinoma (#GEA)!
More info 👉 bit.ly/4xfEgD6